Amrize Ltd (CH:AMRZ)
NYSE:AMRZ
AMRZ Stock Chart & Stats
CHF46.00
--
Market closed
CHF46.00
--
Day’s Range― - ―
52-Week RangeCHF35.20 - CHF51.34
Previous CloseN/A
VolumeN/A
Average Volume (3M)1.06M
Market Cap
CHF21.63B
Enterprise ValueCHF38.96B
Total Cash (Recent Filing)CHF1.10B
Total Debt (Recent Filing)CHF6.67B
Price to Earnings (P/E)―
Beta0.98
Next Earnings
Aug 03, 2026EPS Estimate
0.77Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.10
Shares Outstanding552,735,960
10 Day Avg. Volume963,241
30 Day Avg. Volume1,061,677
Financial Highlights & Ratios
PEG Ratio-3.63
Price to Book (P/B)2.26
Price to Sales (P/S)2.53
P/FCF Ratio21.09
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
CHF51.04Price Target Upside10.96% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering13
EPS Forecast (FY)2.18
Revenue Forecast (FY)CHF9.74B
Bulls Say, Bears Say
Bulls Say
Healthy MarginsAmrize's TTM gross margin (~25.8%) and robust EBITDA margin (~23.7%) underpin durable profitability that supports reinvestment, debt reduction and shareholder programs. Margins remain near industry-competitive levels and provide operating leverage to absorb cyclicality over the next several quarters.
Improved Leverage And LiquidityLeverage has materially improved (debt/equity ~0.53; net leverage ~1.1x) and ~ $6B of liquidity provides financial flexibility. This stronger capital structure lowers refinancing risk, enables sustained capex and M&A funding, and supports dividend/share repurchase execution over the medium term.
Structural Growth Programs & M&AThe ASPIRE cost program (70 bps target, $250M synergies by 2028) combined with capacity investments and the PB Materials acquisition (~$180M revenue, added reserves) create durable margin tailwinds and incremental volumes, supporting multi-year organic growth and margin improvement beyond short-term cycles.
Bears Say
Weakening Free Cash Flow TrendFree cash flow has declined (TTM $1.32B vs $1.42B prior year; FCF growth -7.113) and cash conversion has softened (~66% of net income, operating coverage ~0.68). A persistent FCF weakening could constrain funding for growth capex, M&A or shareholder returns over multiple quarters if not reversed.
Building Envelope Segment WeaknessQ4 Building Envelope revenue fell 11.8% and an $8M warranty charge hit margins. Continued residential roofing softness and warranty exposure create structural cyclic and quality risks that can depress segment profitability and cash generation until volumes and claims normalize.
Elevated Growth CapExManagement plans higher growth CapEx ($900M in 2026 vs $788M in 2025) to expand capacity and debottleneck plants. While strategic, this elevated capital intensity is likely to pressure near-term free cash flow and cash conversion, potentially delaying excess cash availability for buybacks or dividends.
Amrize Ltd News
AMRZ FAQ
What was Amrize Ltd’s price range in the past 12 months?
Amrize Ltd lowest stock price was CHF35.20 and its highest was CHF51.34 in the past 12 months.
What is Amrize Ltd’s market cap?
Amrize Ltd’s market cap is CHF21.63B.
When is Amrize Ltd’s upcoming earnings report date?
Amrize Ltd’s upcoming earnings report date is Aug 03, 2026 which is in 68 days.
How were Amrize Ltd’s earnings last quarter?
Amrize Ltd released its earnings results on Apr 27, 2026. The company reported -CHF0.126 earnings per share for the quarter, missing the consensus estimate of -CHF0.106 by -CHF0.02.
Is Amrize Ltd overvalued?
According to Wall Street analysts Amrize Ltd’s price is currently Undervalued.
Does Amrize Ltd pay dividends?
Amrize Ltd does not currently pay dividends.
What is Amrize Ltd’s EPS estimate?
Amrize Ltd’s EPS estimate is 0.77.
How many shares outstanding does Amrize Ltd have?
Amrize Ltd has 552,735,960 shares outstanding.
What happened to Amrize Ltd’s price movement after its last earnings report?
Amrize Ltd reported an EPS of -CHF0.126 in its last earnings report, missing expectations of -CHF0.106. Following the earnings report the stock price went up 1.277%.
Which hedge fund is a major shareholder of Amrize Ltd?
Currently, no hedge funds are holding shares in CH:AMRZ
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Amrize Ltd Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
CHF51.04 (10.96% Upside)
CHF51.04 (10.96% Upside)
Blogger Sentiment
Bullish
CH:AMRZ Sentiment 70%
Sector Average ―
Sector Average ―
Insider Transactions
Bought Shares
Worth CHF5.6M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 0%
Bearish news 0%
Fundamentals
Return on Equity
10.79%
Trailing 12-Months
Asset Growth
4.63%
Trailing 12-Months
Company Description
Amrize Ltd
Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.
AMRZ Company Deck
AMRZ Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed a predominantly positive outlook: Amrize reported modest full-year revenue growth, strong adjusted EBITDA ($3.0B), robust cash generation (49% conversion), significant margin expansion in Building Materials, clear progress on the ASPIRE cost-savings program, meaningful capacity expansions and a strategic, accretive acquisition (PB Materials). Management also announced a sizeable shareholder return program and provided constructive 2026 guidance (4%–6% revenue, 8%–11% EBITDA). Offsetting these positives are notable near-term challenges in the Building Envelope/residential roofing business (Q4 revenues down 11.8%, $8M warranty charge), a slight company-level Q4 revenue decline (-0.4%), seasonal Q1 headwinds, and the impact of elevated growth CapEx on free cash flow. Overall, the favorable operating momentum, margin initiatives, balance-sheet strength and constructive guidance outweigh the segment-specific softness and near-term headwinds.View all CH:AMRZ earnings summariesAMRZ Stock 12 Month Forecast
Average Price Target
CHF51.04
▲(10.96% Upside)
Options Prices
Currently, No data available
---